- Home
- ANIP vs TWO Comparison
ANIP vs TWO Comparison
Compare ANIP & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- TWO
- Stock Information
- Founded
- ANIP 2001
- TWO 2009
- Country
- ANIP United States
- TWO United States
- Employees
- ANIP N/A
- TWO N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- ANIP Health Care
- TWO Real Estate
- Exchange
- ANIP Nasdaq
- TWO Nasdaq
- Market Cap
- ANIP 1.2B
- TWO 1.2B
- IPO Year
- ANIP N/A
- TWO 2009
- Fundamental
- Price
- ANIP $55.67
- TWO $11.95
- Analyst Decision
- ANIP Buy
- TWO Buy
- Analyst Count
- ANIP 7
- TWO 8
- Target Price
- ANIP $77.33
- TWO $14.18
- AVG Volume (30 Days)
- ANIP 253.7K
- TWO 924.8K
- Earning Date
- ANIP 11-08-2024
- TWO 01-27-2025
- Dividend Yield
- ANIP N/A
- TWO 15.13%
- EPS Growth
- ANIP N/A
- TWO N/A
- EPS
- ANIP N/A
- TWO N/A
- Revenue
- ANIP $555,456,000.00
- TWO $119,476,000.00
- Revenue This Year
- ANIP $25.49
- TWO N/A
- Revenue Next Year
- ANIP $19.92
- TWO N/A
- P/E Ratio
- ANIP N/A
- TWO N/A
- Revenue Growth
- ANIP 23.60
- TWO N/A
- 52 Week Low
- ANIP $52.00
- TWO $11.28
- 52 Week High
- ANIP $70.81
- TWO $14.54
- Technical
- Relative Strength Index (RSI)
- ANIP 42.29
- TWO 49.97
- Support Level
- ANIP $55.29
- TWO $11.72
- Resistance Level
- ANIP $57.33
- TWO $12.01
- Average True Range (ATR)
- ANIP 1.88
- TWO 0.15
- MACD
- ANIP -0.16
- TWO 0.04
- Stochastic Oscillator
- ANIP 5.34
- TWO 65.71
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust primarily focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. Most of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.